Because of their limited applicability to human HFpEF, it is perhaps not surprising that therapeutic agents which were effective in these pre-clinical models often failed in clinical trials
Scientific evidence shows most obese people usually have a decline in GH output
Connect with one of our medical experts today to learn more
Adiels M, Taskinen MR, Packard C, Caslake MJ, Soro-Paavonen A, Westerbacka J, Vehkavaara S, Hakkinen A, Olofsson SO, Yki-Jarvinen H, Boren J (2006) Overproduction of large VLDL particles is driven by increased liver fat content in man
TB-500 requires standard peptide storage protocols but is very stable when properly stored in lyophilized form
Many patients notice significant improvements in their energy and overall well-being after starting treatment